Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)

2. Address

Address1
1801 Research Blvd., Suite 400
 Address2
​
City
ROCKVILLE
 State
MD
 Zip Code
20850
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Ms.
​Nicolette Tapay
​6402500398
​ntapay@accc-cancer.org
5. Senate ID#
​71952-12
7. Client Name Self Check if client is a state or local government or instrumentality
​ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)
6. House ID#
​359550000
TYPE OF REPORT 8. Year
​2026
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​10,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Nicolette Tapay
 Date
4/20/2026 12:58:36 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Health care priorities of ACCC: a) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Inflation Reduction Act implementation, especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339); 8) Extension of Medicare reimbursement for telehealth services (passed in Feb. as part of the Consolidated Appropriations Act of 2026); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renew ACA subsidies and mitigate impact of Medicaid changes in OBBBA); 13) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 14) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Request to Designate April as Cancer Prevention and Early Detection month; 16) Modernize incentives for Advanced Alternative Payment Models (APMs); 17) Stabilize physician payment system and prepare for APMs; 18) Leverage the CMS Innovation Center; 19) Support Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; and 21) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization.



17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Nicolette
Tapay
​
Senior Health Policy Advisor, Senator Ron Wyden (6/2007-7/2009)

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)